Press Releases

Featured Press Releases

Biotechnology Innovation Organization (BIO)…

WASHINGTON, DC (January 7th, 2026) – Today, the Biotechnology Innovation Organization (BIO) announced the launch of the BIO Investment Council (BIC). The newly established council aims to serve small and emerging biotech innovators by increasing…

Learn more

BIO Statement on Changes Announced to the U.S…

WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO) released the following statement on changes announced to the US childhood vaccine schedule.“American health is as unique as America itself…

Learn more

BIO Statement on December 2025 ACIP Meeting

WASHINGTON, D.C. – Phyllis Arthur, Executive Vice President and Head of Health Policy and Programs of the Biotechnology Innovation Organization (BIO) released the following statement on the December 2025 ACIP meeting.“For decades, the CDC’s Advisory…

Learn more

BIO Statement Regarding the UN High Level Panel on Access to Medicines Report

September 14, 2016

Sadly the United Nations High Level Panel ignored the real issues that impact or delay delivery of innovative treatments and cures throughout the developing world, while focusing on policy recommendations in the one area –…

BIO Investor Forum 2016 Programming Announced

September 7, 2016

BIO announced programming for the 15th annual BIO Investor Forum. Held on October 18-19 at the Westin St. Francis Hotel in San Francisco, the BIO Investor Forum explores global investment trends and opportunities in life sciences. Early and mid…

BIO Releases New Report on Renewable Chemical Biorefinery Commercialization

September 7, 2016

BIO released the new report “Advancing the Biobased Economy: Renewable Chemical Biorefinery Commercialization, Progress, and Market Opportunities, 2016 and Beyond,” documenting substantial, ongoing growth in the renewable chemical industry and…

BIO Launches “Innovation Saves” Ad to Highlight Value of Biopharmaceutical Innovation

September 6, 2016

BIO launched a new television ad focused on biopharmaceutical innovation and its unique ability to help both save lives and save money. The new ad, along with its “Innovation Saves” website, is a new chapter in BIO’s Value Campaign, which…

Life Sciences Community Joins Rep. Charlie Dent to Discuss State of the Industry and Positive Impact on Pennsylvania

August 18, 2016

Pennsylvania’s concentration of bioscience employment is nine percent greater than national average

Biotechnology Innovation Organization and Biominas Brasil to Co-Host BIO Latin America Conference

August 3, 2016

Meeting will bring together biotechnology executives, academics and investors from around the globe

New PBS Film and 2016 BIO Animal Biotech Summit Highlight Biotech Solutions to Combating Emerging Infectious Diseases

August 1, 2016

Programming at this year’s Animal Biotech Summit, Advancing One Health through Biotechnology, will look at how biotechnology can be used in emerging infectious disease surveillance and rapid diagnosis, while highlighting the flexibility…

Pennsylvania Governor Wolf Signs Bill Facilitating Patient Access to Interchangeable Biologic Medicines

July 22, 2016

BIO and Pennsylvania Bio commend Governor Tom Wolf for signing critical legislation to create a pathway for the substitution of interchangeable biologic medicines, with appropriate communication to patients and physicians.

BIO Statement on Prescription Drug User Fee Act Goals Letter

July 15, 2016

Washington, D.C. (July 15, 2016) – Biotechnology Innovation Organization (BIO) President and CEO Jim Greenwood released the following statement today regarding the Prescription Drug User Fee Act (PDUFA) VI goals letter:

BIO and Nikon Instruments Inc. Jointly announce a new Program for Research Grade Microscope System for BIO Members

July 15, 2016

BIO and Nikon Instruments Inc. jointly announce a new partnership under the BIO Business Solutions® offerings.

Daily News You Can’t Afford to Miss

Read it in under 3 minutes!

The Good Day BIO newsletter is the only daily newsletter at the intersection of biotech, politics, and policy.